The invention relates to an aleuron product, which has particles consisting of grain aleuron cells, in particular wheat aleuron cells, as well as to a method for its manufacture.
Aleuron is a nutritionally extremely valuable component of grain, in particular of wheat grain. Aleuron is present in wheat grain as a single-cell layer (aleuron layer) between the flour body (endosperm) and shell (pericarp and testa) of the wheat grain. The percent by weight of aleuron in the wheat averages 8.3%.
Aleuron is isolated from bran and further processed using physical, in particular mechanical-abrasive and biological-enzymatic methods. The bran used as the parent material for this purpose is obtained in a conventional manner in a grain mill. In this regard, reference is made to International Patent Application WO 01/15711 A2 of the same applicant.
The aleuron cells of the wheat grain contain the most important nutritional substances of the wheat grain in concentrated form, such as vitamins, minerals, essential fatty acids, nutrient fibers, high-quality protein (albumin), along with special protective substances (bioactive substances, such as polyphenols, lignan, phytin, etc.). Wheat has also been a proven foodstuff for humans and animals for several thousand years.
The high content of vitamins and minerals contribute to overall health, as well as to mental and physical performance.
The nutrient fibers in the aleuron help improve digestion in the large intestine (prebiotic). In addition, ion exchange activity slows resorption in the small intestine, and binds undesired substances. In so doing, they contribute to a long-lasting feeling of satisfaction and detoxification.
Bioactive substances of the aleuron, such as polyphenols, flavonoids, lignan, beta-glucan, etc., help protect against several illnesses afflicting human civilization, such as arterial disease and certain forms of cancer.
The object of the invention is to make aleuron and its constituents useful for human and animal nutrition.
The object is achieved according to the invention by virtue of the fact that the aleuron product mentioned at the outset has finely milled particles consisting of grain aleuron cells, having a maximum length ranging from about one aleuron diameter to 500 μm. In this finely milled form, these aleuron-containing particles can be used in an especially wide variety of ways for human and animal nutrition, in particular as additives to conventional foodstuffs. The longest measure preferably ranges from one aleuron cell diameter to 500 μm in more than 50% of the particles consisting of aleuron cells.
An even finer aleuron product is preferred for certain applications. The longest measure can range from 100-300 μm. The longest measure preferably ranges from 100-300 μm in more than 50% of the particles consisting of aleuron cells. The longest measure can also range from 10-100 μm, wherein the longest measure preferably ranges from 10-100 μm in more than 50% of the particles consisting of aleuron cells here as well.
According to the invention, the particles consisting of aleuron cells contain cell clusters made up of 1 to 200 aleuron cells, wherein preferably more than 50% of the particles consisting of aleuron cells are cell clusters made up of 1 to 200 aleuron cells.
In the somewhat finer aleuron product, the particles consisting of aleuron cells have cell clusters made up of 5 to 100 aleuron cells, wherein preferably more than 50% of its particles consisting of aleuron cells are cell clusters made up of 5 to 100 aleuron cells.
One special property of the aleuron product according to the invention aid that the smallest dimension of the particles consisting of grain aleuron cells roughly corresponds to the size of a single aleuron cell. In other words, the individual cells of the generally single-cell aleuron layer (wheat) are still intact. The fine milling and subsequent screening only determined the size or number of aleuron cells of the cell groups also referred to as clusters.
Even though aleuron is also contained in the seeds of other grain types, use is preferably made of the aleuron cells from wheat bran.
The bioavailability of the substances contained in the aleuron cells and mentioned at the outset depends greatly on the condition of the cell walls of the aleuron cells in the cell clusters according to the invention.
In a special embodiment, the cell walls of all aleuron cells of the particles are undamaged. This can be achieved in a gentle fine milling process. The advantage to this is that the aleuron cell content can be retained over a long period of time. Primarily, the cell constituents are prevented from oxidizing.
In an alternative embodiment, a portion of the aleuron cells of the particles have damaged cell walls. This makes the valuable constituents of the aleuron cells consisting primarily of arabinoxylanes more accessible during digestion than in the case of intact aleuron cells. In order to prevent the cell contents from prematurely oxidizing, various antioxidants can be mixed into the aleuron product according to the invention as needed.
The cell walls of the aleuron cells can be at least partially damaged or weakened enzymatically, chemically, mechanically or thermally. Also possible is a combination of these measures, e.g., a mechanical-enzymatic or mechanical-thermal weakening of the cell walls. Depending on the extent of damage/weakening of the aleuron cell walls, humans or animals can absorb the nutritionally valuable substances more quickly or completely, or perhaps more slowly and incompletely, during the digestive process, wherein the prebiotic effect alone dominates in the latter case due to the cells present in the digestive tract. Specifically adjusting the level of damage to the aleuron cells makes it possible to set the rate at which the nutritionally valuable substances are released in a targeted fashion. Highly damaged aleuron cells lead to a quick and virtually complete digestion of cell contents, while the digestion (fermentation) of slightly damaged cells takes more time.
In a special embodiment, the aleuron product is a mixture consisting of a first standard aleuron product and a second standard aleuron product, wherein it is preferred that first standard aleuron product have primarily undamaged aleuron cells, and the second standard aleuron product have primarily damaged aleuron cells. This makes it possible to manufacture a “tailored” aleuron product that can be adjusted to the physiological requirements of specific individuals (humans or animals).
The second standard aleuron has primarily destroyed aleuron cells, or consist primarily of aleuron cell fragments.
The aleuron product according to the invention preferably has the following composition: 10-30% w/w protein, 5-15% w/w ash, 2-8% w/w fat and 30-60% w/w indigestible or only partially digestible fibers.
In one significant achievement of this invention, the aleuron product according to the invention has more than 90% w/w aleuron, in particular more than 95% w/w aleuron. A practically pure “aleuron powder” an also be prepared according to the invention. Given a product according to the invention based on wheat bran, practically no outer shell particles that would cause the product to turn brown are present any longer. Rather, this highly pure “aleuron powder” according to this invention is approximately white or yellowish to white, and it exhibits practically no dark brown shell particles.
In another embodiment, the aleuron product according to the invention can have shell particles still stemming from the original bran in addition to aleuron cell clusters. This product can be manufactured somewhat more easily and cost-effectively.
The method for manufacturing the aleuron product according to the invention involves the following steps:
Placing a mechanical load on the aleuron particles in step d) makes the nutritionally valuable contents of the aleuron cells more easily accessible for digestion in the individual, and changes the composition (water removal) and taste (debitterizing) of the aleuron product.
In step c), the moisture is preferably set to 14-16% w/w water. Setting the moisture of the sorted aleuron constituents to a value of 10-20% w/w, in particular to 14-16% w/w water, has a positive effect, since is surprisingly improves the taste, primarily debitterizes, the aleuron when combined with the subsequent fine milling.
It is particularly advantageous that step d) be preceded by a step to sort the aleuron constituents out of the mixture. This is because, if too many non-aleuron constituents, such as shell particles, are contained in the mixture to be supplied to fine milling, the relatively hard foreign particles hamper fine milling, practically acting as “spacers” between the friction rolls, thereby protecting the actual aleuron particles (=aleuron cell clusters) against comminution by the rolls.
This sorting process is preferably performed electrostatically, preferably before step c). Electrostatically sorting the aleuron constituents makes it possible to obtain practically pure “aleuron powder”, which can not only be milled even finer, but even strictly visually more resembles a yellowish-white powder than the brownish, finely milled product contaminated with shell particles.
During fine milling, the aleuron constituents are best passed through a roll pair for repeated friction milling, or the aleuron constituents are passed through several sequential roll pairs for repeated friction milling, wherein the roll gap is set practically to zero, and the rolls are pressed together.
The fine milling step is preferably followed by another step for sorting, preferably using a method for the wet separation of the finely milled (micromilled) aleuron constituents. This makes it possible to obtain the mentioned fragments in a range of 50-500 μm, in a range of 100-300 μm, or in a range of 10-100 μm.
Additional advantages, features and possible applications are set forth in the following non-limiting description of preferred exemplary embodiments of the aleuron product based on the drawing, wherein:
The bioavailability of nutritionally valuable constituents in the wheat grain increases for the following forms of ingestion for aleuron:
Whole wheat grain (whole grain)
Shell removed from wheat grain, with adhering aleuron layer (whole bran)
Mixture of “aleuron particles” and “shell particles” (comminuted bran)
Isolated “aleuron particles” (only aleuron cell clusters remain)
Super-finely milled aleuron particles (“aleuron sludge”)
While the increase in bioavailability from 1) to 2), 2) to 3) and 3) to 4) is relatively small, a significant increase in bioavailability could be achieved via super-fine milling according to the invention.
This is illustrated by Table 1: LEURON®, which shows a quantitative comparison between the aleuron ingestion forms 3), 4) and 5).
Key:
3) Mixture of aleuron particles and shell particles
4) Pure aleuron particle powder
5) Super-finely milled aleuron particles
Table 2 shows additional typical compositions for the aleuron preparations according to the invention.
Key:
ASP-1: Aleuron product, manufactured as follows:
Wheat bran containing aleuron and non-aleuron constituents was used as the basis.
The aleuron constituents were mechanically detached from the non-aleuron constituents, thereby yielding a mixture of aleuron constituents and non-aleuron constituents.
The moisture of the mixture was then set to a value of 10-20% w/w water.
The mixture prepared in this way was subjected to super-fine milling (micro-milling) with a distributing roll mill having at least one roll pair. The rolls were operated at varying surface velocities, and pressed against each other.
The resultant product, ASP-1, contains shell particles in addition to aleuron particles (clusters of aleuron cells).
ASP-2: Aleuron product, manufactured as follows
ASP-1 was taken as the basis.
The ASP-1 was enriched to increase the share of aleuron particles.
The sorting of shell particles required for this purpose is accomplished by contact-electrically or triboelectrically charging ASP-1 and then electrostatically separating the shell particles from the aleuron particles.
The resultant product, ASP-1, has a high aleuron particle content.
Number | Date | Country | Kind |
---|---|---|---|
103 07 401.5 | Feb 2003 | DE | national |
103 20 076.2 | May 2003 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CH04/00012 | 1/13/2004 | WO | 8/19/2005 |